SP-420

DB16069InvestigationalSmall molecule

SP-420 is under investigation in clinical trial NCT03801889 (SP-420 in Subjects With Transfusion-dependent Beta-thalassemia or Other Rare Anemias).

Chemical structure of SP-420
Formula / weight
C16H21NO6S · 355.41 g/mol (avg)
Code names
SP-420

Resolves to

Compound
UNIIWBX54NZ436CAS911714-45-9ChEMBLCHEMBL1092665
Structure
InChIKeyYASYAEVZKXPYIZ-MRXNPFEDSA-NSMILESCOCCOCCOC1=CC(O)=C(C=C1)C1=N[C@](C)(CS1)C(O)=O

What you can answer from here — as of April 23, 2025

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of SP-420, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In